Pages that link to "Q40476851"
Jump to navigation
Jump to search
The following pages link to Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. (Q40476851):
Displaying 50 items.
- Leishmaniasis worldwide and global estimates of its incidence (Q21134611) (← links)
- Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era (Q26769062) (← links)
- Developments in the treatment of visceral leishmaniasis (Q28256441) (← links)
- Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent (Q28475431) (← links)
- Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis (Q28483976) (← links)
- Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India (Q28538265) (← links)
- Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh (Q28546021) (← links)
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (Q29038941) (← links)
- Epidemiologic Correlates of Mortality among Symptomatic Visceral Leishmaniasis Cases: Findings from Situation Assessment in High Endemic Foci in India (Q30379995) (← links)
- The immunology of Leishmania/HIV co-infection. (Q30428365) (← links)
- No evidence for association between SLC11A1 and visceral leishmaniasis in India (Q31012721) (← links)
- Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study (Q31032931) (← links)
- Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda (Q33325763) (← links)
- Complexities of assessing the disease burden attributable to leishmaniasis (Q33380173) (← links)
- The burden of human African trypanosomiasis (Q33395338) (← links)
- Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy (Q33401607) (← links)
- Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India (Q33578783) (← links)
- Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters (Q33753259) (← links)
- Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis (Q33786681) (← links)
- Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs (Q33828879) (← links)
- Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. (Q33843296) (← links)
- Immune regulation during chronic visceral leishmaniasis (Q33881718) (← links)
- Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal (Q34087309) (← links)
- Global distribution of outbreaks of water-associated infectious diseases (Q34163883) (← links)
- Management of visceral leishmaniasis in rural primary health care services in Bihar, India (Q34443655) (← links)
- Identification and functional characterization of Leishmania donovani secretory peroxidase: delineating its role in NRAMP1 regulation (Q34551387) (← links)
- The household costs of visceral leishmaniasis care in south-eastern Nepal (Q34613587) (← links)
- Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India (Q34738791) (← links)
- Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India (Q35031888) (← links)
- Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India (Q35105397) (← links)
- Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis (Q35154482) (← links)
- Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent (Q35156774) (← links)
- Metagenomic analysis of taxa associated with Lutzomyia longipalpis, vector of visceral leishmaniasis, using an unbiased high-throughput approach (Q35198800) (← links)
- How do health care providers deal with kala-azar in the Indian subcontinent? (Q35351899) (← links)
- IL10 Variant g.5311A Is Associated with Visceral Leishmaniasis in Indian Population (Q35571129) (← links)
- Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis (Q35597658) (← links)
- Optimal dosing of miltefosine in children and adults with visceral leishmaniasis (Q36086339) (← links)
- Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review (Q36094815) (← links)
- Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison (Q36147081) (← links)
- Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. (Q36289626) (← links)
- Developments in diagnosis and antileishmanial drugs (Q36355665) (← links)
- Short-Course Treatment Regimen of Indian Visceral Leishmaniasis with an Indian Liposomal Amphotericin B Preparation (Fungisome™). (Q36455848) (← links)
- The relationship between leishmaniasis and AIDS: the second 10 years (Q36538814) (← links)
- Social and Economic Burden of Human Leishmaniasis (Q36644367) (← links)
- Endemic characteristics of infantile visceral leishmaniasis in the People's Republic of China (Q36891860) (← links)
- Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal (Q37538994) (← links)
- The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? (Q37712177) (← links)
- Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis (Q37811110) (← links)
- Leishmaniasis: new insights from an old and neglected disease. (Q37870821) (← links)
- Protective immunity and vaccination against cutaneous leishmaniasis. (Q38015852) (← links)